These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 6764112)
1. [Clinical trial of cisplatin in the treatment of ovarian carcinoma]. Yoshizawa H; Kanazawa K; Takeuchi S; Okamura Y; Goto S; Kajiwara T Gan To Kagaku Ryoho; 1982 May; 9(5):822-30. PubMed ID: 6764112 [TBL] [Abstract][Full Text] [Related]
2. [Ovarian adenocarcinoma stage III and IV treated by a combination of adriamycin, cyclophosphamide, 5-fluorouracil and cis-DDP. Therapeutic role of cis-DDP in this combination]. Pouillart P; Bretaudeau B; Palangie T; Jouve M; Garcia-Giralt E; Asselain B Bull Cancer; 1982; 69(5):434-42. PubMed ID: 6891903 [TBL] [Abstract][Full Text] [Related]
3. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas. Colón-Otero G; Marschke R; Camoriano JK; Sorensen JM; Sloan JA; Richardson RL Cancer J Sci Am; 1997; 3(5):297-302. PubMed ID: 9327154 [TBL] [Abstract][Full Text] [Related]
4. 4'-epi-doxorubicin in combination with cisplatin in advanced ovarian cancer. Martoni A; Tomasi L; Farabegoli G; Fruet F; Pannuti F Cancer Treat Rep; 1984 Nov; 68(11):1391-3. PubMed ID: 6594196 [TBL] [Abstract][Full Text] [Related]
5. [Combination chemotherapy with cyclophosphamide, adriamycin, cisplatin, nimustine(ACNU), and methotrexate (EACAM) in advanced adenocarcinoma of the lung]. Nakanishi F; Sugiishi M; Ogasawara T; Sugiura I; Kinoshita T; Ito Y; Hoshino A Gan To Kagaku Ryoho; 1985 Jun; 12(6):1339-44. PubMed ID: 3859252 [TBL] [Abstract][Full Text] [Related]
6. Six-drug chemotherapy (hexamethylmelamine, doxorubicin, cisplatin, cyclophosphamide, methotrexate, and 5-FU; CHAMP-5) for ovarian carcinoma: alternating sequences of combination regimens. Pasmantier MW; Coleman M; Silver RT; Ballard WP Cancer Treat Rep; 1985 Jun; 69(6):689-93. PubMed ID: 3926310 [TBL] [Abstract][Full Text] [Related]
7. [Combination chemotherapy with cisplatin, ifosfamide and adriamycin in patients with advanced transitional cell carcinoma of the urinary tract]. Yoshimoto J; Nasu Y; Akagi T; Obama T; Tsushima T; Ozaki Y; Matsumura Y; Ohmori H; Asahi T; Ohkita K Gan To Kagaku Ryoho; 1985 Jun; 12(6):1312-7. PubMed ID: 4039919 [TBL] [Abstract][Full Text] [Related]
8. [Clinical trial of China-made carboplatin in advanced ovarian cancer--an analysis of 53 cases]. Liu LY Zhonghua Zhong Liu Za Zhi; 1992 Nov; 14(6):461-3. PubMed ID: 1304482 [TBL] [Abstract][Full Text] [Related]
9. Treatment of patients with upper gastrointestinal carcinomas. Ajani JA Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-72-S19-76. PubMed ID: 9427271 [TBL] [Abstract][Full Text] [Related]
10. Weekly cis-diamminedichloroplatinum(II): active third-line chemotherapy in ovarian carcinoma--a preliminary report. Piver MS; Lele S; Barlow J Cancer Treat Rep; 1980; 64(12):1379-82. PubMed ID: 7193521 [TBL] [Abstract][Full Text] [Related]
11. [Combination chemotherapy using cyclophosphamide, adriamycin, and cisplatin in recurrent or advanced endometrial cancer--a preliminary report]. Baba S; Kashimura M; Shinohara M; Kusano S; Sasayama T; Hamasaki K Gan No Rinsho; 1989 Feb; 35(3):371-7. PubMed ID: 2926985 [TBL] [Abstract][Full Text] [Related]
12. Chemotherapy of malignant ovarian tumors; therapeutic results of ifosfamide. Yakushiji M; Tsunawaki A; Nishida T; Nishimura H; Natsuaki Y; Inoue T; Kato T Acta Obstet Gynaecol Jpn; 1981 Jul; 33(7):1071-6. PubMed ID: 7304132 [TBL] [Abstract][Full Text] [Related]
13. [Chemotherapy of metastatic urothelial carcinoma]. Kihara K; Sakuramoto T; Washizuka M; Kawai T; Ogawa M Gan To Kagaku Ryoho; 1982 Nov; 9(11):2046-7. PubMed ID: 6892194 [TBL] [Abstract][Full Text] [Related]
14. Combination chemotherapy for ovarian carcinoma with cyclophosphamide, adriamycin, and cis-dichlorodiammineplatinum(II) after failure of initial chemotherapy. Bruckner HW; Ratner LH; Cohen CJ; Wallach R; Kabakow B; Greenspan EM; Holland JF Cancer Treat Rep; 1978 Jul; 62(7):1021-3. PubMed ID: 688244 [TBL] [Abstract][Full Text] [Related]
15. Intraperitoneal administration of cisplatin and 5-fluorouracil in residual ovarian cancer: a Phase II Gynecologic Oncology Group trial. Braly PS; Berek JS; Blessing JA; Homesley HD; Averette H Gynecol Oncol; 1995 Feb; 56(2):164-8. PubMed ID: 7896179 [TBL] [Abstract][Full Text] [Related]
16. [Treatment of advanced ovarian cancer with cis-dichlorodiammine platinum (CDDP) as single agent or cddp in combination with adriamycin (ADM)]. Nishimura H; Yamada T; Hagio Y; Inoue T; Tsunawaki A; Yakushiji M; Kato T Gan To Kagaku Ryoho; 1983 Apr; 10(4 Pt 1):938-43. PubMed ID: 6683483 [TBL] [Abstract][Full Text] [Related]
17. [Significance and effects of intraperitoneal cisplatin administration for ovarian cancer]. Shimizu A; Ookubo K; Hasegawa J; Endoh T; Fujiwara O; Yoda A; Okuyama D; Narabayashi A; Kimura T; Takahashi J; Notake Y Gan To Kagaku Ryoho; 1999 Oct; 26(12):1801-5. PubMed ID: 10560398 [TBL] [Abstract][Full Text] [Related]
18. Dose intensive combination platinum and cyclophosphamide in the treatment of patients with advanced untreated epithelial ovarian cancer. Shapiro JD; Rothenberg ML; Sarosy GA; Steinberg SM; Adamo DO; Reed E; Ozols RF; Kohn EC Cancer; 1998 Nov; 83(9):1980-8. PubMed ID: 9806657 [TBL] [Abstract][Full Text] [Related]
19. Combined-modality therapy for esophageal cancer: phase I trial of escalating doses of paclitaxel in combination with cisplatin, 5-fluorouracil, and high-dose radiation before esophagectomy. Weiner LM; Colarusso P; Goldberg M; Dresler C; Coia LR Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-93-S19-95. PubMed ID: 9427276 [TBL] [Abstract][Full Text] [Related]
20. Phase II trial of combination intraperitoneal cisplatin and 5-fluorouracil in previously treated patients with advanced ovarian cancer: long-term follow-up. Morgan RJ; Braly P; Leong L; Shibata S; Margolin K; Somlo G; McNamara M; Longmate J; Schinke S; Raschko J; Nagasawa S; Kogut N; Najera L; Johnson D; Doroshow JH Gynecol Oncol; 2000 Jun; 77(3):433-8. PubMed ID: 10831355 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]